Kodiak Sciences Inc (FRA:K27)
€ 3.546 0.072 (2.07%) Market Cap: 211.94 Mil Enterprise Value: 80.00 Mil PE Ratio: 0 PB Ratio: 0.96 GF Score: 37/100

Kodiak Sciences Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 08, 2021 / 08:40PM GMT
Release Date Price: €65.5 (+4.80%)
Graig Suvannavejh
Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst

Yes. Okay. Good afternoon, everyone. Welcome to the 4:40 p.m. session on day 1 of the 42nd Annual Goldman Sachs Global Health Care Conference. My name is Graig Suvannavejh. I cover both U.S. and European biopharma names here at the firm. It's my pleasure to be hosting Kodiak Sciences today in a fireside chat. And with that, let me welcome Victor Perlroth, who's CEO of the company; and John Borgeson, who is CFO of the company, who is just slightly to the side of your screen.

Questions & Answers

Graig Suvannavejh
Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst

But with that said, Victor, it's good to see you. Thank you again for your participation. And maybe if I can just start everyone at a very high level for those who are perhaps newer to the Kodiak Sciences story or perhaps revisiting it after some time, can you please just tell us a little bit more about the company and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot